Literature DB >> 27920318

Survey Highlights Differences In Medicaid Coverage For Substance Use Treatment And Opioid Use Disorder Medications.

Colleen M Grogan1, Christina Andrews2, Amanda Abraham3, Keith Humphreys4, Harold A Pollack5, Bikki Tran Smith6, Peter D Friedmann7.   

Abstract

The Affordable Care Act requires state Medicaid programs to cover substance use disorder treatment for their Medicaid expansion population but allows states to decide which individual services are reimbursable. To examine how states have defined substance use disorder benefit packages, we used data from 2013-14 that we collected as part of an ongoing nationwide survey of state Medicaid programs. Our findings highlight important state-level differences in coverage for substance use disorder treatment and opioid use disorder medications across the United States. Many states did not cover all levels of care required for effective substance use disorder treatment or medications required for effective opioid use disorder treatment as defined by American Society of Addiction Medicine criteria, which could result in lack of access to needed services for low-income populations. Project HOPE—The People-to-People Health Foundation, Inc.

Entities:  

Keywords:  Access To Care; Disparities; Health Reform; Medicaid; Mental Health/Substance Abuse

Mesh:

Substances:

Year:  2016        PMID: 27920318      PMCID: PMC5304419          DOI: 10.1377/hlthaff.2016.0623

Source DB:  PubMed          Journal:  Health Aff (Millwood)        ISSN: 0278-2715            Impact factor:   6.301


  21 in total

1.  State health care reform: behavioral health services under Medicaid managed care: the uncertain implications of state variation.

Authors:  K W Hanson; H A Huskamp
Journal:  Psychiatr Serv       Date:  2001-04       Impact factor: 3.084

2.  Health reform and the scope of benefits for mental health and substance use disorder services.

Authors:  Rachel L Garfield; Judith R Lave; Julie M Donohue
Journal:  Psychiatr Serv       Date:  2010-11       Impact factor: 3.084

3.  Massachusetts's experience suggests coverage alone is insufficient to increase addiction disorders treatment.

Authors:  Victor A Capoccia; Kyle L Grazier; Christopher Toal; James H Ford; David H Gustafson
Journal:  Health Aff (Millwood)       Date:  2012-05       Impact factor: 6.301

4.  Medicaid coverage of medications to treat alcohol and opioid dependence.

Authors:  Tami L Mark; Robert Lubran; Elinore F McCance-Katz; Mady Chalk; John Richardson
Journal:  J Subst Abuse Treat       Date:  2015-04-16

Review 5.  Buprenorphine maintenance versus placebo or methadone maintenance for opioid dependence.

Authors:  Richard P Mattick; Courtney Breen; Jo Kimber; Marina Davoli
Journal:  Cochrane Database Syst Rev       Date:  2014-02-06

6.  The Affordable Care Act will revolutionize care for substance use disorders in the United States.

Authors:  Keith Humphreys; Richard G Frank
Journal:  Addiction       Date:  2014-06-26       Impact factor: 6.526

7.  Factors Associated With Use of ASAM Criteria and Service Provision in a National Sample of Outpatient Substance Abuse Treatment Units.

Authors:  Emmeline Chuang; Rebecca Wells; Jeffrey A Alexander; Peter D Friedmann; I-Heng Lee
Journal:  J Addict Med       Date:  2009-09       Impact factor: 3.702

8.  Despite Resources From The ACA, Most States Do Little To Help Addiction Treatment Programs Implement Health Care Reform.

Authors:  Christina Andrews; Amanda Abraham; Colleen M Grogan; Harold A Pollack; Clifford Bersamira; Keith Humphreys; Peter Friedmann
Journal:  Health Aff (Millwood)       Date:  2015-05       Impact factor: 6.301

9.  The impact of prior authorization on buprenorphine dose, relapse rates, and cost for Massachusetts Medicaid beneficiaries with opioid dependence.

Authors:  Robin E Clark; Jeffrey D Baxter; Bruce A Barton; Gideon Aweh; Elizabeth O'Connell; William H Fisher
Journal:  Health Serv Res       Date:  2014-07-09       Impact factor: 3.402

10.  The looming expansion and transformation of public substance abuse treatment under the Affordable Care Act.

Authors:  Jeffrey A Buck
Journal:  Health Aff (Millwood)       Date:  2011-08       Impact factor: 6.301

View more
  40 in total

1.  Medication for opioid use disorder treatment and specialty outpatient substance use treatment outcomes: Differences in retention and completion among opioid-related discharges in 2016.

Authors:  Melanie S Askari; Silvia S Martins; Pia M Mauro
Journal:  J Subst Abuse Treat       Date:  2020-05-11

2.  Discharge against medical advice from hospitalizations for substance use disorders: The potential impact of the Affordable Care Act.

Authors:  He Zhu; Li-Tzy Wu
Journal:  Drug Alcohol Depend       Date:  2019-02-16       Impact factor: 4.492

3.  Outpatient care for opioid use disorder among the commercially insured: Use of medication and psychosocial treatment.

Authors:  Alisa B Busch; Shelly F Greenfield; Sharon Reif; Sharon-Lise T Normand; Haiden A Huskamp
Journal:  J Subst Abuse Treat       Date:  2020-05-22

4.  Geographic Disparities in Availability of Opioid Use Disorder Treatment for Medicaid Enrollees.

Authors:  Amanda J Abraham; Christina M Andrews; Marissa E Yingling; Jerry Shannon
Journal:  Health Serv Res       Date:  2017-03-27       Impact factor: 3.402

5.  The Affordable Care Act Transformation of Substance Use Disorder Treatment.

Authors:  Amanda J Abraham; Christina M Andrews; Colleen M Grogan; Thomas D'Aunno; Keith N Humphreys; Harold A Pollack; Peter D Friedmann
Journal:  Am J Public Health       Date:  2017-01       Impact factor: 9.308

6.  Self-Help Groups And Medication Use In Opioid Addiction Treatment: A National Analysis.

Authors:  Hefei Wen; Benjamin G Druss; Brendan Saloner
Journal:  Health Aff (Millwood)       Date:  2020-05       Impact factor: 6.301

7.  Impact Of Long-Term Buprenorphine Treatment On Adverse Health Care Outcomes In Medicaid.

Authors:  Hillary Samples; Arthur Robin Williams; Stephen Crystal; Mark Olfson
Journal:  Health Aff (Millwood)       Date:  2020-05       Impact factor: 6.301

8.  Development of a Cascade of Care for responding to the opioid epidemic.

Authors:  Arthur Robin Williams; Edward V Nunes; Adam Bisaga; Frances R Levin; Mark Olfson
Journal:  Am J Drug Alcohol Abuse       Date:  2019-01-24       Impact factor: 3.829

9.  Medicaid coverage in substance use disorder treatment after the affordable care act.

Authors:  Christina M Andrews; Harold A Pollack; Amanda J Abraham; Colleen M Grogan; Clifford S Bersamira; Thomas D'Aunno; Peter D Friedmann
Journal:  J Subst Abuse Treat       Date:  2019-04-09

10.  Risk factors for discontinuation of buprenorphine treatment for opioid use disorders in a multi-state sample of Medicaid enrollees.

Authors:  Hillary Samples; Arthur Robin Williams; Mark Olfson; Stephen Crystal
Journal:  J Subst Abuse Treat       Date:  2018-09-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.